Bloomberg: Universe's 15min chart triggers Bollinger Bands Expanding Downward, Bearish Marubozu
ByAinvest
Thursday, Oct 16, 2025 11:02 am ET1min read
GLTO--
Galecto Inc., a company focused on developing small-molecule drugs targeting fibrosis and cancer, saw the largest increase in momentum, rising from a score of 9.3 to 96.64. The stock is trading far above its 50-day moving average of $3.77 at $15.70. Xenetic Biosciences Inc., which develops cancer treatments that help the immune system fight tumors, saw a momentum gain of 75.56 points, rising from 21.97 to 97.53. The stock is also trading above its 50-day moving average of $3.23 at $9.70.
Universe Pharmaceuticals Inc. saw a momentum increase from 12.95 to 82.24, with the stock trading above its 50-day moving average of $4.02 at $6.40. Alaunos Therapeutics, Inc., which develops cell therapies using a patient's own immune cells to fight cancer, gained 68.77 points, rising from 15.88 to 84.65. The stock is trading above its 50-day moving average of $2.43 at $3.95.
Price action at the time of publication on Thursday showed Galecto stock trading 28.27% higher at $13.85, Xenetic shares trading 9.27% lower at $9.40, Universe shares trading 33.30% lower at $6.31, and Alaunos shares trading 6.49% higher at $3.96.
However, the 15-minute chart for Universe Pharmaceuticals has recently triggered a Bollinger Bands Expanding Downward signal, accompanied by a Bearish Marubozu pattern on October 16th at 11:00 AM. This indicates that the market trend is currently being driven by selling pressure, with sellers exerting control over market dynamics. As a result, it is likely that the bearish momentum will persist.
TCRT--
UPC--
XBIO--
The 15-minute chart for Universe has recently triggered a Bollinger Bands Expanding Downward signal, accompanied by a Bearish Marubozu pattern on October 16th at 11:00 AM. This indicates that the market trend is currently being driven by selling pressure, with sellers exerting control over market dynamics. As a result, it is likely that the bearish momentum will persist.
Healthcare and biotech stocks have been lagging behind broader markets this year, but a growing number of names have shown significant improvements in momentum. According to Benzinga's Edge Stock Rankings system, four biotech stocks have posted sharp increases in bullish momentum over the past week. These stocks include Galecto Inc. (GLTO), Xenetic Biosciences Inc. (XBIO), Universe Pharmaceuticals Inc. (UPC), and Alaunos Therapeutics, Inc. (TCRT).Galecto Inc., a company focused on developing small-molecule drugs targeting fibrosis and cancer, saw the largest increase in momentum, rising from a score of 9.3 to 96.64. The stock is trading far above its 50-day moving average of $3.77 at $15.70. Xenetic Biosciences Inc., which develops cancer treatments that help the immune system fight tumors, saw a momentum gain of 75.56 points, rising from 21.97 to 97.53. The stock is also trading above its 50-day moving average of $3.23 at $9.70.
Universe Pharmaceuticals Inc. saw a momentum increase from 12.95 to 82.24, with the stock trading above its 50-day moving average of $4.02 at $6.40. Alaunos Therapeutics, Inc., which develops cell therapies using a patient's own immune cells to fight cancer, gained 68.77 points, rising from 15.88 to 84.65. The stock is trading above its 50-day moving average of $2.43 at $3.95.
Price action at the time of publication on Thursday showed Galecto stock trading 28.27% higher at $13.85, Xenetic shares trading 9.27% lower at $9.40, Universe shares trading 33.30% lower at $6.31, and Alaunos shares trading 6.49% higher at $3.96.
However, the 15-minute chart for Universe Pharmaceuticals has recently triggered a Bollinger Bands Expanding Downward signal, accompanied by a Bearish Marubozu pattern on October 16th at 11:00 AM. This indicates that the market trend is currently being driven by selling pressure, with sellers exerting control over market dynamics. As a result, it is likely that the bearish momentum will persist.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet